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ABSTRAST 
This study was aimed at looking at the influence of pregnancy on fibrinogen concentration and thrombin time 
(TT) levels. A total of 195 pregnant women between 18 and 35 years were recruited, 59 were in their first 
trimester (group A), 61 second trimester (group B) and 75 the third trimester (group C). A total of 150 apparently 
healthy non pregnant women were used as normal control (group D). Blood samples which was collected from 
each of the participants after obtaining informed consent was tested for the fibrinogen concentration using Clauss 
method and thrombin time using two stage method. The study was approved by Nnamdi Azikiwe University 
Teaching Hospital Ethical Committee Nnewi. ANOVA and students t-test were used for statistical analysis. The 
results showed that fibrinogen concentration (mg/dL) were significantly higher (p<0.05) in group A, B and C as 
compared with the control group. TT (s) were significantly higher (p<0.05) in group A, B and C compared with 
the control group. This study therefore suggests that the increase in these coagulation factors observed are due to 
increased thrombin generation, inflammatory state of pregnancy and fibrinogen being an acute-phase protein. It 
is important to obtain a baseline of these parameters for all pregnant women during antenatal visits, in order to 
detect any abnormality early.  
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INTRODUCTION 
Pregnancy is the carrying of one or more offspring known as foetus or embryo inside the womb of a female. In 
pregnancy, physiological changes affect coagulation and fibrinolytic system. These physiological changes are 
seen in blood volumes, blood pressure, gastrointestinal system, metabolism, renal physiology, the endocrine 
system, haematological parameters, liver enzymes (Jamjute et al., 2009). Many clotting factors increase and 
anticoagulation factors decrease causing augmented coagulation and decrease fibrinolysis (Dahlman et al., 1999; 
Thorton and Dauglas, 2010). Haemostasis abnormalities have been associated with various complications of 
pregnancy (Awodu and Enosolease, 2003). These changes result in a state of hypercoagulability and are likely 
due to hormonal changes and increase the risk of thromboembolism (Salter et al., 2007). These changes in 
haemostatic system are considered to be in preparation for the maintenance of the placental function which 
occurs during pregnancy. These substances stimulate clot formation to stop maternal blood loss. As placental 
blood flow is up to 700ml/min considerable haemorrhage can occur if clotting fails (Dahlman et al., 1999). 
Increase in the blood level of these coagulation factors is maximal in the 3rd trimester of pregnancy Fibrinogen 
is a soluble plasma glycoprotein protein produced in the liver by hepatocytes. It is a large molecule, made up of 
two identical halves, each half composed of three protein chains (α alpha, β beta, and γ gamma). Thrombin 
cleaves fibrinogen with the release of fibrinopeptides A and B, producing fibrin monomer which then 
polymerizes and is stabilized by the action of factor XIII, Fibrin is then cross linked by factor XIII to form a clot. 
In its natural form, fibrinogen can form bridges between platelets, by binding to their GpIIb/IIIa surface 
membrane proteins. Thrombin is the essential enzyme product of the blood coagulation enzymatic cascade. 
Thrombin is a "trypsin-like" serine protease protein that in humans is encoded by the F2 gene (Degen and Davie, 
1987). Prothrombin (coagulation factor II) is proteolytically cleaved to form thrombin in the first step of the 
coagulation cascade, which ultimately results in the stemming of blood loss. Thrombin in turn acts as a serine 
protease that converts soluble fibrinogen into insoluble strands of fibrin, as well as catalyzing many other 
coagulation-related reactions. In the blood coagulation pathway, thrombin acts to convert factor XI to XIa, VIII 
to VIIIa, V to Va, and fibrinogen to fibrin. In a country like Nigeria, high maternal mortality and fetal wastage is 
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associated with high incidence of antepartum and postpartum haemorrhage, high parity, home deliveries not 
supervised by trained personnel, inadequate and inaccessible health facilities and late presentation of cases to 
health facilities. The aim of this study was to determine to what extent pregnancy affects fibrinogen 
concentration and thrombin time when compared with a control group of non pregnant women. 
 
SUBJECTS AND METHODS  
Subjects: One hundred and ninety five (195) pregnant women aged 18-35 years attending antenatal clinic in 
Nnamdi Azikiwe University Teaching Hospital (NAUTH) Nnewi between September and November 2011 were 
screened. The questionnaires were completed and their informed consent was obtained. The information 
obtained using the questionnaires include age, parity, past history of pregnancy related problem(s), duration of 
pregnancy, history of any miscarriage. Out of 195 pregnant women recruited, 59 were in the first trimester 
(group A), 61 second trimester (group B) and 75 third trimesters (group C). One hundred and fifty (150) non 
pregnant women (group D) were also screened and they served as controls. 
One thousand eight hundred milliliter (1.8mls) of venous blood was collected from each of the subjects, and  was 
added into Trisodium Citrate container containing 0.2mls of Trisodium Citrate (1:9 dilution) mixed immediately 
by reverse uniform inversion for fibrinogen concentration and thrombin time. The sample was spun with a bench 
centrifuge at 3000rpm for 10mins. Then the clear plasma was collected into a clean dry plastic container. The 
test was performed using Rayto Semi Auto coagulation analyser RT-2204C model manufactured by Rayto Life 
and Analytical sciences Co., Ltd.  
Exclusion Criteria: Pregnant and control subjects with bleeding disorders, underlying coagulation disorders, 
pregnancy related problem, patients on anticoagulants therapy and patients that refused to give consent were 
excluded. 
Study Sites: This study was carried out at Nnamdi Azikiwe University Teaching Hospital (NAUTH), Nnewi 
with the approval of the Nnamdi Azikiwe University Teaching Hospital Ethical Committee. The samples were 
collected in the Antenatal Clinic while analysis was carried out in the Hospital Laboratory. 
Determination of Thrombin Time (TT): This was done using the Two Stage Method. It measures the time it 
takes plasma to clot, when thrombin acts upon fibrinogen converting it to insoluble fibrin in the common 
pathway. The TT reagent was reconstituted with 1ml of distilled water and mixed by inversion and allowed to 
stand at room temperature. 100µL of sample was added to the test cuvette, and then 50µL of the reconstituted TT 
reagent was added. The clotting time was recorded in seconds. One normal control plasma sample was setup for 
each batch of tests. 
Determination of Fibrinogen concentration: This was done using the Clauss Method. In the presence of high 
concentration of thrombin, diluted plasma gives a required time of clot formation which is inversely proportional 
to the fibrinogen concentration. The sample is diluted with 450µL of imidazole buffer to 50µL of sample to give 
a 1:10 dilution. 200µL of prediluted sample is added to the test cuvette, the sample was incubated for 5mins at 
37
 O
C. Then 100µL of bovine thrombin is added. The time of clot was recorded in seconds and the concentration 
in mg/dL. 
RESULTS: Table 1 showed comparisons of mean±SD TT (s) and fibrinogen concentration (mg/dL) in pregnant 
women in first trimester (group A), second trimester (group B) and third trimester (group C), and control non 
pregnant women (group D). The mean±SD fibrinogen concentration 505.97±178.22 for the pregnant women in 
the group C respectively compared with that of 404.26±143.92 for group A, 422.33±126.75 for group B and 
283.87±98.90 for group D, (in each case) showed higher significant different (P<0.05). Also the fibrinogen 
concentration 404.26±143.92 for pregnant women in group A showed a higher mean difference compared with 
the mean value 283.87±98.70 in group D (P<0.05). Moreover, the mean value fibrinogen concentration 
422.33±126.75 for group B compared with 283.87±98.70 in group D was significantly higher (P<0.05). 
However, the comparison in fibrinogen concentration mean value between the pregnant women in the group A 
and B showed no significant value (P>0.05). 
 The mean±SD TT in pregnant women in the group A 16.79±0.82, B 15.59±1.46, C 16.47±1.32 and control 
group D 14.87±1.08, compared amongst the group showed significant different in value (F 52.988; P<0.05). The 
within group comparison showed that TT 16.79±0.82 for pregnant women in group A compared with that of 
group B 15.59±1.46 and group D 14.87±1.08 in each case, showed higher significant difference (P<0.05). Also 
the TT 15.59±1.46 for pregnant women in group B compared with 16.47±1.32 for pregnant women in the group 
C showed significantly lower difference (P<0.05). Moreover, the mean±SD of TT 15.59±1.46 for pregnant 
women in the group B showed higher significant difference compared with the mean value 14.84±1.08 in group 
D (P<0.05). Furthermore, there was higher significant difference in the mean±SD of TT 16.47±1.32 for pregnant 
women in the group C compared with that of 14.87±1.07 in group D (P<0.05). However, the mean values in TT, 
compared between the pregnant women in group A and C showed similar mean value (P>0.05).  
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DISCUSSION 
Pregnancy is a complex physiological process with many physiological changes as seen in increased coagulation 
factors and decreased anticoagulation factors. During pregnancy there are significant changes in coagulation in 
the direction of coagulability, thus decreasing bleeding complications in connection with delivery (Olorunshola 
et al., 2011). Thrombin time obtained in pregnant subject was significantly higher than that obtained in the 
control subjects. This was also observed in the works of (Ekaterine and Ilija, 2005), the slightly elevated TT was 
as a result of increased thrombin generation in pregnancy which also accounts for the hypercoagulability state in 
pregnancy, and also as a result a gross elevation of fibrinogen concentration (Dacie and Lewis, 2002). In our 
study, there is a significant elevated value of fibrinogen concentration in pregnancy when compared with the non 
pregnant control subject. Duperray et al (1997) reported a significant increase in fibrinogen concentration which 
was mainly due to the inflammatory state of pregnancy and also fibrinogen being an acute-phase protein. Works 
of (Duperray et al. 1997, Romero et al. 2007) saw a significant elevated fibrinogen in pregnancy; this elevation 
may be as a result of its involvement in both cell–cell interaction and the interaction of cell and extracellular 
matrix like collagen. This highly elevated fibrinogen concentration was markedly seen in the third trimester. 
 
CONCLUSION 
During pregnancy, the activation of coagulation is counterbalanced by haemostatic balance thus decreasing 
bleeding complication in connection with delivery. Physiological changes in pregnancy affect the coagulation 
and fibrinolytic system, which responses in preparation for protecting against excessive haemorrhage or blood 
coagulation at parturition. The results of this research work conclude that there is a significantly higher 
difference in TT and fibrinogen in pregnancy when compared with non pregnant control women. 
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TABLE 1: Mean±SD of TT(s) and fibrinogen concentration (mg/dL), compared among pregnant women 
in first (group A), second (group B), third trimester (group C) and control non pregnant women (group D). 
     Group                                      TT (s)                                       Fibrinogen (mg/dL)     
   A (n=59)                               16.79± 0.82                                       404.26± 143.92 
 
   B  (n=61)                              15.59± 1.46                                       422.33± 126.75 
 
   C  (n=75)                              16.47± 1.32                                       505.97± 178.22 
 
   D (n=150)                             14.87± 1.08                                         283.87± 98.90  
 F (P) Value                           52.988(0.000)                                       51.720(0.000) 
 
    A vs B                                     0.000
 
                                                     0.878 
 
    A vs C                                     0.414                                                      0.000     
 
    A vs D                                     0.000
 
                                                     0.000
 
 
    B vs C                                     0.000
 
                                                     0.002
 
 
    B vs D                                     0.000
 
                                                     0.000
 
 
    C vs D                                     0.000
 
                                                     0.000 
                  
 
Key:  
F (P) Value= Mean±SD of TT and fibrinogen concentration, compared among pregnant women in first, second, 
third trimester and control non pregnant women (using ANOVA). 
A vs B= Mean±SD of TT and fibrinogen concentration, compared between pregnant women in first and second 
trimester (using student t test). 
A vs C= Mean±SD of TT and fibrinogen, compared between pregnant women in first and third trimester (using 
student t test). 
A vs D= Mean±SD of TT and fibrinogen concentration, compared between pregnant women in first trimester 
and control non pregnant women (using student t test). 
B vs C= Mean±SD of TT and fibrinogen concentration, compared between pregnant women in second and third 
trimester (using student t test). 
B vs D= Mean±SD of TT and fibrinogen concentration, compared between pregnant women in second trimester 
and control non pregnant women (using student t test). 
C vs D= Mean±SD of TT and fibrinogen concentration, compared between pregnant women in third trimester 
and control non pregnant women (using student t test). 
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